{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:33:26Z","timestamp":1790836406939,"version":"4.1.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T00:00:00Z","timestamp":1619568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2016\/24059-2"],"award-info":[{"award-number":["2016\/24059-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Type 1 diabetes (T1DM) is a chronic disease characterized by hyperglycemia due to a deficiency in endogenous insulin production, resulting from pancreatic beta cell death. Persistent hyperglycemia leads to enhanced oxidative stress and liver injury. Several studies have evaluated the anti-diabetic and protective effects of probiotic strains in animal models. In the present study, we investigated, through histopathological and biochemical analyses, the effects of eight weeks of administration of\n                    <jats:italic>Saccharomyces boulardii (S. boulardii)<\/jats:italic>\n                    yeast on the liver of streptozotocin (STZ) induced diabetic C57BL\/6 mice. Our results demonstrated that\n                    <jats:italic>S. boulardii<\/jats:italic>\n                    attenuates hepatocytes hydropic degeneration and hepatic vessels congestion in STZ-induced diabetic mice. The treatment attenuated the oxidative stress in diabetic mice leading to a reduction of carbonylated protein concentration and increased activity of antioxidant enzymes superoxide dismutase and glutathione peroxidase, compared to untreated diabetic animals. The results also show the beneficial influence of\n                    <jats:italic>S. boulardii<\/jats:italic>\n                    in regulating the hepatic concentration of renin angiotensin system (RAS) peptides. Therefore, our results demonstrated that\n                    <jats:italic>S. boulardii<\/jats:italic>\n                    administration to STZ-induced diabetic mice reduces oxidative stress and normalizes the concentration of RAS peptides, supporting the hypothesis that this yeast may have a role as a potential adjunctive therapy to attenuate diabetes-induced liver injury.\n                  <\/jats:p>","DOI":"10.1038\/s41598-021-88497-w","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T06:04:55Z","timestamp":1619589895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Saccharomyces boulardii modulates oxidative stress and renin angiotensin system attenuating diabetes-induced liver injury in mice"],"prefix":"10.1038","volume":"11","author":[{"given":"Leticia","family":"Barssotti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel C. M. E.","family":"Abreu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Beatriz P.","family":"Brand\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel C. M. F.","family":"Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana G.","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A. C.","family":"Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle D. S.","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e1tia","family":"De Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dulce E.","family":"Casarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00edvia B.","family":"Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla R.","family":"Taddei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana S.","family":"Cunha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,4,28]]},"reference":[{"key":"88497_CR1","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","volume":"314","author":"GS Eisenbarth","year":"1986","unstructured":"Eisenbarth, G. S. Type I diabetes mellitus. A chronic autoimmune disease. N. Engl. J. Med. 314, 1360\u20131368 (1986).","journal-title":"N. Engl. J. Med."},{"key":"88497_CR2","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","volume":"383","author":"MA Atkinson","year":"2014","unstructured":"Atkinson, M. A., Eisenbarth, G. S. & Michels, A. W. Type 1 diabetes. Lancet (London, England) 383, 69\u201382 (2014).","journal-title":"Lancet (London, England)"},{"key":"88497_CR3","doi-asserted-by":"publisher","first-page":"17016","DOI":"10.1038\/nrdp.2017.16","volume":"3","author":"A Katsarou","year":"2017","unstructured":"Katsarou, A. et al. Type 1 diabetes mellitus. Nat. Rev. Dis. Prim. 3, 17016 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"88497_CR4","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1002\/jbt.10058","volume":"17","author":"AC Maritim","year":"2003","unstructured":"Maritim, A. C., Sanders, R. A. & Watkins, J. B. Diabetes, oxidative stress, and antioxidants: A review. J. Biochem. Mol. Toxicol. 17, 24\u201338 (2003).","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"88497_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.nu.16.070196.000341","volume":"16","author":"B Halliwell","year":"1996","unstructured":"Halliwell, B. Antioxidants in human health and disease. Annu. Rev. Nutr. 16, 33\u201350 (1996).","journal-title":"Annu. Rev. Nutr."},{"key":"88497_CR6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S0014-5793(97)01159-9","volume":"416","author":"SS Korshunov","year":"1997","unstructured":"Korshunov, S. S., Skulachev, V. P. & Starkov, A. A. High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Lett. 416, 15\u201318 (1997).","journal-title":"FEBS Lett."},{"key":"88497_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bbrc.2010.02.071","volume":"393","author":"JMC Gutteridge","year":"2010","unstructured":"Gutteridge, J. M. C. & Halliwell, B. Antioxidants: Molecules, medicines, and myths. Biochem. Biophys. Res. Commun. 393, 561\u2013564 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"88497_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2337\/diabetes.48.1.1","volume":"48","author":"JW Baynes","year":"1999","unstructured":"Baynes, J. W. & Thorpe, S. R. Role of oxidative stress in diabetic complications: A new perspective on an old paradigm. Diabetes 48, 1\u20139 (1999).","journal-title":"Diabetes"},{"key":"88497_CR9","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.2174\/092986712803341520","volume":"19","author":"V S\u00e1nchez-Valle","year":"2012","unstructured":"S\u00e1nchez-Valle, V., Ch\u00e1vez-Tapia, N. C., Uribe, M. & M\u00e9ndez-S\u00e1nchez, N. Role of oxidative stress and molecular changes in liver fibrosis: A review. Curr. Med. Chem. 19, 4850\u20134860 (2012).","journal-title":"Curr. Med. Chem."},{"key":"88497_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4172\/2165-7092.1000133","volume":"04","author":"FS Evangelista","year":"2014","unstructured":"Evangelista, F. S. Complications of type 1 diabetes mellitus are associated with renin angiotensin system: The role of physical exercise as therapeutic tool. Pancreat. Disord. Ther. 04, 1\u20137 (2014).","journal-title":"Pancreat. Disord. Ther."},{"key":"88497_CR11","first-page":"1039","volume":"286","author":"DB Vidotti","year":"2004","unstructured":"Vidotti, D. B. et al. High glucose concentration stimulates intracellular renin activity and angiotensin II generation in rat mesangial cells. Am. J. Physiol. 286, 1039\u20131045 (2004).","journal-title":"Am. J. Physiol."},{"key":"88497_CR12","doi-asserted-by":"publisher","first-page":"3297","DOI":"10.2337\/db08-0805","volume":"57","author":"VP Singh","year":"2008","unstructured":"Singh, V. P., Le, B., Khode, R., Baker, K. M. & Kumar, R. Intracellular angiotensin II production in diabetic rats is correlated with cardiomyocyte apoptosis, oxidative stress, and cardiac fibrosis. Diabetes 57, 3297\u20133306 (2008).","journal-title":"Diabetes"},{"key":"88497_CR13","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/jcb.20797","volume":"98","author":"SH Ko","year":"2006","unstructured":"Ko, S. H. et al. High glucose increases extracellular matrix production in pancreatic stellate cells by activating the renin-angiotensin system. J. Cell. Biochem. 98, 343\u2013355 (2006).","journal-title":"J. Cell. Biochem."},{"key":"88497_CR14","first-page":"215","volume":"I","author":"E Taskin","year":"2017","unstructured":"Taskin, E. & Guven, C. Local renin-angiotensin system at liver and crosstalk with hepatic diseases. Renin-Angiotensin Syst. I, 215\u2013239 (2017).","journal-title":"Renin-Angiotensin Syst."},{"key":"88497_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/S0016-5085(03)00695-4","volume":"125","author":"R Bataller","year":"2003","unstructured":"Bataller, R. et al. Activated human hepatic stellate cells express the renin-angiotensin system and synthesize angiotensin II. Gastroenterology 125, 117\u2013125 (2003).","journal-title":"Gastroenterology"},{"key":"88497_CR16","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3920\/BM2015.0069","volume":"7","author":"LK Stenman","year":"2016","unstructured":"Stenman, L. K., Burcelin, R. & Lahtinen, S. Establishing a causal link between gut microbes, body weight gain and glucose metabolism in humans: Towards treatment with probiotics. Benef. Microbes 7, 11\u201322 (2016).","journal-title":"Benef. Microbes"},{"key":"88497_CR17","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1475-2891-13-60","volume":"13","author":"AC Gomes","year":"2014","unstructured":"Gomes, A. C., Bueno, A. A., de Souza, R. G. M. & Mota, J. F. Gut microbiota, probiotics and diabetes. Nutr. J. 13, 60 (2014).","journal-title":"Nutr. J."},{"key":"88497_CR18","first-page":"157","volume":"6","author":"LV McFarland","year":"1993","unstructured":"McFarland, L. V. & Bernasconi, P. Saccharomyces boulardii: A review of an innovative biotherapeutic agent. Microb. Ecol. Health Dis. 6, 157\u2013171 (1993).","journal-title":"Microb. Ecol. Health Dis."},{"key":"88497_CR19","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1017\/S000711451200517X","volume":"110","author":"DG Duman","year":"2013","unstructured":"Duman, D. G. et al. Saccharomyces boulardii ameliorates clarithromycin- and methotrexate-induced intestinal and hepatic injury in rats. Br. J. Nutr. 110, 493\u2013499 (2013).","journal-title":"Br. J. Nutr."},{"key":"88497_CR20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1111\/apt.13344","volume":"42","author":"H Szajewska","year":"2015","unstructured":"Szajewska, H. & Ko\u0142odziej, M. Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 42, 793\u2013801 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"88497_CR21","doi-asserted-by":"publisher","first-page":"e01011","DOI":"10.1128\/mBio.01011-14","volume":"5","author":"A Everard","year":"2014","unstructured":"Everard, A., Matamoros, S., Geurts, L., Delzenne, N. M. & Cani, P. D. Saccharomyces boulardii administration changes gut microbiota and reduces hepatic steatosis, low-grade inflammation, and fat mass in obese and type 2 diabetic db\/db mice. MBio 5, e01011-e1014 (2014).","journal-title":"MBio"},{"key":"88497_CR22","doi-asserted-by":"publisher","DOI":"10.2337\/db18-2365-PUB","author":"ABP Brand\u00e3o","year":"2018","unstructured":"Brand\u00e3o, A. B. P. et al. Saccharomyces Boulardii attenuates autonomic cardiovascular dysfunction and modulates inflammatory cytokines in diabetic mice. Diabetes https:\/\/doi.org\/10.2337\/db18-2365-PUB (2018).","journal-title":"Diabetes"},{"key":"88497_CR23","doi-asserted-by":"publisher","first-page":"901","DOI":"10.3920\/BM2019.0056","volume":"10","author":"RCMF Albuquerque","year":"2019","unstructured":"Albuquerque, R. C. M. F. et al. Saccharomyces boulardii Tht 500101 changes gut microbiota and ameliorates hyperglycaemia, dyslipidaemia, and liver inflammation in streptozotocin-diabetic mice. Benef. Microbes 10, 901\u2013912 (2019).","journal-title":"Benef. Microbes"},{"key":"88497_CR24","doi-asserted-by":"publisher","first-page":"e3000411","DOI":"10.1371\/journal.pbio.3000411","volume":"18","author":"N Percie du Sert","year":"2020","unstructured":"Percie du Sert, N. et al. Reporting animal research: Explanation and elaboration for the ARRIVE guidelines 2.0. PLOS Biol. 18, e3000411 (2020).","journal-title":"PLOS Biol."},{"key":"88497_CR25","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1248\/bpb.29.1110","volume":"29","author":"K Hayashi","year":"2006","unstructured":"Hayashi, K., Kojima, R. & Ito, M. Strain differences in the diabetogenic activity of streptozotocin in mice. Biol. Pharm. Bull. 29, 1110\u20131119 (2006).","journal-title":"Biol. Pharm. Bull."},{"key":"88497_CR26","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1258\/la.2010.010090","volume":"45","author":"MC Deeds","year":"2011","unstructured":"Deeds, M. C. et al. Single dose streptozotocin-induced diabetes: Considerations for study design in islet transplantation models. Lab. Anim. 45, 131\u2013140 (2011).","journal-title":"Lab. Anim."},{"key":"88497_CR27","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2144\/000112257","volume":"42","author":"MR Lamprecht","year":"2007","unstructured":"Lamprecht, M. R., Sabatini, D. M. & Carpenter, A. E. Cell Profiler: Free, versatile software for automated biological image analysis. Biotechniques 42, 71\u201375 (2007).","journal-title":"Biotechniques"},{"key":"88497_CR28","first-page":"139","volume":"2","author":"LB Sant\u2019Anna","year":"2011","unstructured":"Sant\u2019Anna, L. B., Sant\u2019Anna, N. & Parolini, O. Application of computer assisted image analysis for identifying and quantifying liver fibrosis in a experimental model. J. Comput. Interdiscip. Sci. 2, 139\u2013148 (2011).","journal-title":"J. Comput. Interdiscip. Sci."},{"key":"88497_CR29","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/S0076-6879(94)33041-7","volume":"233","author":"AZ Reznick","year":"1994","unstructured":"Reznick, A. Z. & Packer, L. Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 233, 357\u2013363 (1994).","journal-title":"Methods Enzymol."},{"key":"88497_CR30","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/0891-5849(91)90002-K","volume":"10","author":"B Gonzalez Flecha","year":"1991","unstructured":"Gonzalez Flecha, B., Llesuy, S. & Boveris, A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver, and muscle. Free Radic. Biol. Med. 10, 93\u2013100 (1991).","journal-title":"Free Radic. Biol. Med."},{"key":"88497_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1042\/bj1340707","volume":"134","author":"A Boveris","year":"1973","unstructured":"Boveris, A. & Chance, B. The mitochondrial generation of hydrogen peroxide General properties and effect of hyperbaric oxygen. Biochem. J. 134, 707\u2013716 (1973).","journal-title":"Biochem. J."},{"key":"88497_CR32","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S0076-6879(84)05015-1","volume":"105","author":"L Floh\u00e9","year":"1984","unstructured":"Floh\u00e9, L. & G\u00fcnzler, W. A. Assays of glutathione peroxidase. Methods Enzymol. 105, 114\u2013121 (1984).","journal-title":"Methods Enzymol."},{"key":"88497_CR33","first-page":"1","volume":"10","author":"X Han","year":"2015","unstructured":"Han, X. et al. Knockout of the TauT gene predisposes C57BL\/6 mice to streptozotocin-induced diabetic nephropathy. PLoS ONE 10, 1\u201313 (2015).","journal-title":"PLoS ONE"},{"key":"88497_CR34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.2220\/biomedres.36.63","volume":"36","author":"TKC Le","year":"2015","unstructured":"Le, T. K. C. et al. Bifidobacterium species lower serum glucose, increase expressions of insulin signaling proteins, and improve adipokine profile in diabetic mice. Biomed. Res. 36, 63\u201370 (2015).","journal-title":"Biomed. Res."},{"key":"88497_CR35","doi-asserted-by":"publisher","first-page":"e2912","DOI":"10.1002\/dmrr.2912","volume":"33","author":"F Memarrast","year":"2017","unstructured":"Memarrast, F. et al. Comparative evaluation of probiotics effects on plasma glucose, lipid, and insulin levels in streptozotocin-induced diabetic rats. Diabetes. Metab. Res. Rev. 33, e2912 (2017).","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"88497_CR36","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/dmrr.2665","volume":"32","author":"E Razmpoosh","year":"2016","unstructured":"Razmpoosh, E., Javadi, M., Ejtahed, H.-S. & Mirmiran, P. Probiotics as beneficial agents in the management of diabetes mellitus: A systematic review. Diabetes. Metab. Res. Rev. 32, 143\u2013168 (2016).","journal-title":"Diabetes. Metab. Res. Rev."},{"key":"88497_CR37","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/BF03191026","volume":"33","author":"H Al-Salami","year":"2008","unstructured":"Al-Salami, H. et al. Probiotic treatment reduces blood glucose levels and increases systemic absorption of gliclazide in diabetic rats. Eur. J. Drug Metab. Pharmacokinet. 33, 101\u2013106 (2008).","journal-title":"Eur. J. Drug Metab. Pharmacokinet."},{"key":"88497_CR38","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.3390\/nu10101457","volume":"10","author":"X Meng","year":"2018","unstructured":"Meng, X., Li, S., Li, Y., Gan, R. Y. & Li, H. B. Gut microbiota\u2019s relationship with liver disease and role in hepatoprotection by dietary natural products and probiotics. Nutrients 10, 1457 (2018).","journal-title":"Nutrients"},{"key":"88497_CR39","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41598-017-01271-9","volume":"7","author":"L Yu","year":"2017","unstructured":"Yu, L. et al. Saccharomyces boulardii administration changes gut microbiota and attenuates D-galactosamine-induced liver injury. Sci. Rep. 7, 1359 (2017).","journal-title":"Sci. Rep."},{"key":"88497_CR40","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1007\/s10753-014-0019-7","volume":"38","author":"M Li","year":"2014","unstructured":"Li, M., Zhu, L., Xie, A. & Yuan, J. Oral administration of Saccharomyces boulardii ameliorates carbon tetrachloride-induced liver fibrosis in rats via reducing intestinal permeability and modulating gut microbial composition. Inflammation 38, 170\u2013179 (2014).","journal-title":"Inflammation"},{"key":"88497_CR41","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2337\/diab.40.4.405","volume":"40","author":"JW Baynes","year":"1991","unstructured":"Baynes, J. W. Role of oxidative stress in development of complications in diabetes. Diabetes 40, 405\u2013412 (1991).","journal-title":"Diabetes"},{"key":"88497_CR42","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1016\/j.fct.2012.07.026","volume":"50","author":"K Shukla","year":"2012","unstructured":"Shukla, K., Dikshit, P., Tyagi, M. K., Shukla, R. & Gambhir, J. K. Ameliorative effect of Withania coagulans on dyslipidemia and oxidative stress in nicotinamide\u2013streptozotocin induced diabetes mellitus. Food Chem. Toxicol. 50, 3595\u20133599 (2012).","journal-title":"Food Chem. Toxicol."},{"key":"88497_CR43","first-page":"1","volume":"2016","author":"SA Sheweita","year":"2016","unstructured":"Sheweita, S. A., Mashaly, S., Newairy, A. A., Abdou, H. M. & Eweda, S. M. Changes in oxidative stress and antioxidant enzyme activities in streptozotocin-induced diabetes mellitus in rats: Role of Alhagi maurorum extracts. Oxid. Med. Cell. Longev. 2016, 1\u20138 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"88497_CR44","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1590\/S0102-86502013000700005","volume":"28","author":"AN Lucchesi","year":"2013","unstructured":"Lucchesi, A. N., de Freitas, N. T., Cassettari, L. L., Marques, S. F. G. & Spadella, C. T. Diabetes mellitus triggers oxidative stress in the liver of alloxan-treated rats: a mechanism for diabetic chronic liver disease. Acta Cir. Bras. 28, 502\u2013508 (2013).","journal-title":"Acta Cir. Bras."},{"key":"88497_CR45","first-page":"447","volume":"40","author":"N Bukan","year":"2003","unstructured":"Bukan, N. et al. Lipid peroxidation and scavenging enzyme levels in the liver of streptozotocin-induced diabetic rats. Indian J. Biochem. Biophys. 40, 447\u2013450 (2003).","journal-title":"Indian J. Biochem. Biophys."},{"key":"88497_CR46","doi-asserted-by":"publisher","first-page":"521","DOI":"10.3390\/nu9050521","volume":"9","author":"Y Wang","year":"2017","unstructured":"Wang, Y. et al. Antioxidant properties of probiotic bacteria. Nutrients 9, 521 (2017).","journal-title":"Nutrients"},{"key":"88497_CR47","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12906-017-1591-9","volume":"17","author":"M Fakruddin","year":"2017","unstructured":"Fakruddin, M., Hossain, M. N. & Ahmed, M. M. Antimicrobial and antioxidant activities of Saccharomyces cerevisiae IFST062013, a potential probiotic. BMC Complement. Altern. Med. 17, 1\u201311 (2017).","journal-title":"BMC Complement. Altern. Med."},{"key":"88497_CR48","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1002\/jsfa.8147","volume":"97","author":"S Datta","year":"2017","unstructured":"Datta, S., Timson, D. J. & Annapure, U. S. Antioxidant properties and global metabolite screening of the probiotic yeast Saccharomyces cerevisiae var. boulardii. J. Sci. Food Agric. 97, 3039\u20133049 (2017).","journal-title":"J. Sci. Food Agric."},{"key":"88497_CR49","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1172\/JCI118304","volume":"96","author":"KS Lee","year":"1995","unstructured":"Lee, K. S., Buck, M., Houglum, K. & Chojkier, M. Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest. 96, 2461\u20132468 (1995).","journal-title":"J. Clin. Invest."},{"key":"88497_CR50","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1016\/S1357-2725(02)00179-6","volume":"35","author":"PS Leung","year":"2003","unstructured":"Leung, P. S. & Chappell, M. C. A local pancreatic renin-angiotensin system: Endocrine and exocrine roles. Int. J. Biochem. Cell Biol. 35, 838\u2013846 (2003).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"88497_CR51","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1093\/ajh\/hpv054","volume":"28","author":"J Wysocki","year":"2015","unstructured":"Wysocki, J., Ye, M. & Batlle, D. Plasma and kidney angiotensin peptides: importance of the aminopeptidase A\/angiotensin III axis. Am. J. Hypertens. 28, 1418\u20131426 (2015).","journal-title":"Am. J. Hypertens."},{"key":"88497_CR52","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.jhep.2007.03.008","volume":"47","author":"CB Herath","year":"2007","unstructured":"Herath, C. B. et al. Upregulation of hepatic angiotensin-converting enzyme 2 (ACE2) and angiotensin-(1\u20137) levels in experimental biliary fibrosis. J. Hepatol. 47, 387\u2013395 (2007).","journal-title":"J. Hepatol."},{"key":"88497_CR53","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1111\/j.1440-1746.2008.05461.x","volume":"23","author":"JS Lubel","year":"2008","unstructured":"Lubel, J. S., Herath, C. B., Burrell, L. M. & Angus, P. W. Liver disease and the renin-angiotensin system: Recent discoveries and clinical implications. J. Gastroenterol. Hepatol. 23, 1327\u20131338 (2008).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"88497_CR54","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1042\/CS20110036","volume":"121","author":"S Bosnyak","year":"2011","unstructured":"Bosnyak, S. et al. Relative affinity of angiotensin peptides and novel ligands at AT1 and AT2 receptors. Clin. Sci. (Lond) 121, 297\u2013303 (2011).","journal-title":"Clin. Sci. (Lond)"},{"key":"88497_CR55","doi-asserted-by":"publisher","DOI":"10.5772\/65949","author":"N Cruz-Diaz","year":"2017","unstructured":"Cruz-Diaz, N., Wilson, B. A. & Chappell, M. C. Peptidases and the renin-angiotensin system: The Alternative angiotensin-(1\u20137) cascade. Enzyme Inhibit. Activ. https:\/\/doi.org\/10.5772\/65949 (2017).","journal-title":"Enzyme Inhibit. Activ."},{"key":"88497_CR56","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v9.i2.74","author":"V Souza-Mello","year":"2017","unstructured":"Souza-Mello, V. Hepatic structural enhancement and insulin resistance amelioration due to AT1 receptor blockade. World J. Hepatol. https:\/\/doi.org\/10.4254\/wjh.v9.i2.74 (2017).","journal-title":"World J. Hepatol."},{"key":"88497_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep18300","volume":"5","author":"K Gopal","year":"2015","unstructured":"Gopal, K. et al. Attrition of hepatic damage inflicted by angiotensin II with \u03b1-tocopherol and \u03b2-carotene in experimental apolipoprotein e knock-out mice. Sci. Rep. 5, 1\u201315 (2015).","journal-title":"Sci. Rep."},{"key":"88497_CR58","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1161\/HYPERTENSIONAHA.107.103242","volume":"51","author":"SH Padia","year":"2008","unstructured":"Padia, S. H. et al. Conversion of renal angiotensin II to angiotensin III is critical for AT2 receptor-mediated natriuresis in rats. Hypertension 51, 460\u2013465 (2008).","journal-title":"Hypertension"},{"key":"88497_CR59","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/B978-0-323-53367-6.00011-X","volume-title":"Nephrology and Fluid\/electrolyte Physiology (Third Edition)","author":"A Natarajan","year":"2019","unstructured":"Natarajan, A., Villar, V. A. M. & Jose, P. A. Renal Modulation: The Renin-Angiotensin System. In Nephrology and Fluid\/electrolyte Physiology (Third Edition) 165\u2013188 (Elsevier Inc, Amsterdam, 2019)."},{"key":"88497_CR60","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1042\/CS20070026","volume":"113","author":"FJ Warner","year":"2007","unstructured":"Warner, F. J., Lubel, J. S., McCaughan, G. W. & Angus, P. W. Liver fibrosis: a balance of ACEs?. Clin. Sci. 113, 109\u2013118 (2007).","journal-title":"Clin. Sci."},{"key":"88497_CR61","first-page":"1","volume":"8","author":"ND Salih","year":"2009","unstructured":"Salih, N. D., Muslih, R. K. & Hamoodi, S. R. Histological liver changes in streptozotocin induced diabetic mice. Int. Med. J. Malaysia 8, 1\u20134 (2009).","journal-title":"Int. Med. J. Malaysia"},{"key":"88497_CR62","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.acthis.2006.03.005","volume":"108","author":"A Guven","year":"2006","unstructured":"Guven, A. et al. Effects of melatonin on streptozotocin-induced diabetic liver injury in rats. Acta Histochem. 108, 85\u201393 (2006).","journal-title":"Acta Histochem."},{"key":"88497_CR63","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/BF00202202","volume":"428","author":"NC Nayak","year":"1996","unstructured":"Nayak, N. C. et al. The nature and significance of liver cell vacuolation following hepatocellular injury: An analysis based on observations on rats rendered tolerant to hepatotoxic damage. Virchows Arch. 428, 353\u2013365 (1996).","journal-title":"Virchows Arch."},{"key":"88497_CR64","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1016\/j.jhep.2005.03.027","volume":"43","author":"S Haga","year":"2005","unstructured":"Haga, S. et al. Compensatory recovery of liver mass by Akt-mediated hepatocellular hypertrophy in liver-specific STAT3-deficient mice. J. Hepatol. 43, 799\u2013807 (2005).","journal-title":"J. Hepatol."},{"key":"88497_CR65","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1053\/jhep.2001.21326","volume":"33","author":"P Nagy","year":"2000","unstructured":"Nagy, P. et al. Reconstitution of liver mass via cellular hypertrophy in the rat. Hepatology 33, 339\u2013345 (2000).","journal-title":"Hepatology"},{"key":"88497_CR66","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1016\/j.cub.2012.05.016","volume":"22","author":"Y Miyaoka","year":"2012","unstructured":"Miyaoka, Y. et al. Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration. Curr. Biol. 22, 1166\u20131175 (2012).","journal-title":"Curr. Biol."},{"key":"88497_CR67","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/S0140-6736(99)00219-6","volume":"355","author":"MC Kew","year":"2000","unstructured":"Kew, M. C. Serum aminotransferase concentration as evidence of hepatocellular damage. Lancet 355, 591\u2013592 (2000).","journal-title":"Lancet"},{"key":"88497_CR68","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/0009-9120(93)90123-N","volume":"26","author":"E Schmidt","year":"1993","unstructured":"Schmidt, E. & Schmidt, F. W. Enzyme diagnosis of liver disease. Clin. Biochem. 26, 241\u2013251 (1993).","journal-title":"Clin. Biochem."},{"key":"88497_CR69","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.abb.2007.07.023","volume":"466","author":"P Lindblom","year":"2007","unstructured":"Lindblom, P. et al. Isoforms of alanine aminotransferases in human tissues and serum: Differential tissue expression using novel antibodies. Arch. Biochem. Biophys. 466, 66\u201377 (2007).","journal-title":"Arch. Biochem. Biophys."},{"key":"88497_CR70","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.tox.2007.11.021","volume":"245","author":"J Ozer","year":"2008","unstructured":"Ozer, J., Ratner, M., Shaw, M., Bailey, W. & Schomaker, S. The current state of serum biomarkers of hepatotoxicity. Toxicology 245, 194\u2013205 (2008).","journal-title":"Toxicology"},{"key":"88497_CR71","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1093\/clinchem\/24.11.1971","volume":"24","author":"R Rej","year":"1978","unstructured":"Rej, R. Aspartate aminotransferase activity and isoenzyme proportions in human liver tissues. Clin. Chem. 24, 1971\u20131979 (1978).","journal-title":"Clin. Chem."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88497-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88497-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88497-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T02:27:27Z","timestamp":1670034447000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-021-88497-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,28]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["88497"],"URL":"https:\/\/doi.org\/10.1038\/s41598-021-88497-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,28]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9189"}}